Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a prominent player in the biopharmaceutical industry, focused on the research, development, manufacturing, and marketing of a comprehensive range of medication products. As a major Chinese pharmaceutical enterprise, Jiangsu Hengrui Pharmaceuticals excels in oncology, anesthesia, imaging, and contrast agents, making significant strides in these therapeutic areas. The company is recognized for its dedication to innovation, with an extensive portfolio ranging from antineoplastic drugs to modern medicinal therapies. Headquartered in Lianyungang, Jiangsu Province, the company serves diverse healthcare needs both domestically and internationally. It plays a crucial role in advancing public health by providing accessible and innovative pharmaceutical solutions. Given its strategic partnerships and robust pipeline development, Jiangsu Hengrui Pharmaceuticals is considered a vital contributor to the pharmaceutical landscape, catering primarily to the growing demands of the healthcare sector in China and progressively expanding its influence globally.